Soy protein supports cardiovascular health by downregulating hydroxymethylglutaryl–coenzyme A reductase and sterol regulatory element-binding protein–2 and increasing antioxidant enzyme activity in rats with dextran sodium sulfate–induced mild systemic inflammation

School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA 92182, USA.
Nutrition research (Impact Factor: 2.47). 12/2011; 31(12):922-8. DOI: 10.1016/j.nutres.2011.09.027
Source: PubMed


Animal and human studies have indicated that the presence of soy in the diet improves cardiovascular health. Inflammation plays a pivotal role in the progression of cardiovascular disease (CVD). However, little is known about how dextran sodium sulfate (DSS)-induced systemic inflammation impacts overall heart health and, correspondingly, how soy protein modulates risk of CVD development in DSS-induced systemic inflammation. We hypothesized that soy protein-fed rats would have a lower risk of CVD by beneficial alteration of gene expression involving lipid metabolism and antioxidant capacity in DSS-induced systemic inflammation. Forty Sprague-Dawley rats were divided into 4 groups: casein, casein + DSS, soy protein, and soy protein + DSS. After 26 days, inflammation was induced in one group from each diet by incorporating 3% DSS in drinking water for 48 hours. Soy protein-fed rats had lower final body weights (P = .010), epididymal fat weights (P = .049), total cholesterol (P < .001), and low-density lipoprotein cholesterol (P < .001). In regard to gene expression, soy protein-fed rats had lower sterol regulatory element-binding protein-2 (P = .032) and hydroxymethylglutaryl-coenzyme A reductase (P = .028) levels and higher low-density lipoprotein receptor levels (P = .036). Antioxidant enzyme activity of superoxide dismutase and catalase was higher among the soy protein groups (P = .037 and P = .002, respectively). These results suggest that soy protein positively influences cardiovascular health by regulating serum lipids through modified expression of sterol regulatory element-binding protein-2 and its downstream genes (ie, hydroxymethylglutaryl-coenzyme A reductase and low-density lipoprotein receptor) and by promoting the antioxidant enzyme activity of superoxide dismutase and catalase.

Download full-text


Available from: Rachel Straub, Oct 04, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Owing to the beneficial health effects on human cardiovascular system, soybeans and soy-related products have been a focus of intensive research. Soy isoflavones are known to be primarily responsible for the soy-related biological effects including anti-platelet activity but its in vivo relevancy has not been fully verified. Here we compared the role of adenosine, an active ingredient abundant in black soybean (BB) extract, in the anti-platelet effects of BB, to that of soy isoflavones. At the concentrations existing in BB, isoflavones such as genistein and daidzein could not attenuate collagen-induced platelet aggregation, however, adenosine significantly inhibited platelet aggregation with an equivalent potency to BB, suggesting that adenosine may be the major bioactive component. Consistently, the anti-aggregatory effects of BB disappeared after treatment of adenosine receptor antagonists. The effects of BB are mediated by adenosine through intracellular cAMP and subsequent attenuation of calcium mobilization. Of note, adenosine and BB significantly reduced platelet fibrinogen binding and platelet adhesion, other critical events for platelet activation, which were not affected by isoflavones. Taken together, we demonstrated that adenosine might be the major active ingredient for BB-induced anti-platelet activity, which will shed new light on the roles of adenosine as a bioactive compound in soybeans and soy-related food.
    Thrombosis Research 01/2013; 131(3). DOI:10.1016/j.thromres.2013.01.002 · 2.45 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Dark chocolate contains high levels of antioxidants which are linked to a reduced risk of cardiovascular disease. Chocolate blooming occurs after exposure to high temperatures. Although bloomed chocolate is safe for human consumption, it is not known whether or not the biological function of bloomed chocolate is affected. We hypothesized that bloomed chocolate would reduce the antioxidant potential and lipid-lowering properties of chocolate through altered expression of related genes. Thirty Sprague-Dawley rats were divided into 3 groups and fed either the control (CON), regular dark chocolate (RDC), or bloomed dark chocolate (BDC) diet. After 3 weeks, serum lipid levels and antioxidant capacity were measured. Hepatic expression of key genes was determined by real time polymerase chain reaction (PCR). Sensory characteristics of bloomed versus regular chocolate were assessed in 28 semi-trained panelists. Rats fed RDC exhibited greater serum antioxidant capacities compared to the CON (P < .05). Antioxidant levels of BDC were not different from RDC or CON. Both RDC and BDC lowered TG compared to CON (P < .05). The rats fed RDC had higher high-density lipoprotein levels compared to the CON (P < .05). In rats given RDC, fatty acid synthase gene expression was down-regulated and low-density lipoprotein receptor transcription was up-regulated (P < .05). Sensory panelists preferred the appearance and surface smoothness of the regular chocolate compared to bloomed chocolate (P < .001). Although blooming blunted the robust antioxidant response produced by regular dark chocolate, these results suggest that bloomed dark chocolate yields similarly beneficial effects on most blood lipid parameters or biomarkers. However, regular dark chocolate may be more beneficial for the improvement of antioxidant status and modulation of gene expression involved in lipid metabolism and promoted greater sensory ratings.
    Nutrition research 05/2013; 33(5):414-421. DOI:10.1016/j.nutres.2013.03.004 · 2.47 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The combination of a lipid-lowering diet and scientifically proven nutraceutical supplements have the ability to significantly reduce LDL cholesterol, decrease LDL particle number, increase LDL particle size, lower triglycerides and VLDL, increase total and type 2 b HDL and improve HDL functionality. However, even the best of diets and proper nutrition may not be enough to obtain the desired lipid levels, thus a combination of nutrition and nutritional supplements are useful and effective in reaching serum lipid goals. In addition, inflammation, oxidative stress and vascular immune responses are decreased. In several prospective clinical trials, coronary heart disease and cardiovascular disease have been reduced with optimal nutrition and/or administration of several nutraceutical supplements, including omega 3 fatty acids, red yeast rice, α-linolenic acid and niacin. A combined program of nutrition and nutraceutical supplements represents a scientifically valid alternative for patients who are statin intolerant, cannot take other drugs for the treatment of dyslipidemia or in those who prefer alternative therapies. This new approach to decrease dyslipidemic-induced vascular disease recognizes and treats the multiple steps that are involved in the development of atherosclerosis. The purpose of this review is to establish the scientific validity, efficacy and safety of combined nutrition and nutraceutical supplements for treating dyslipidemia without drugs for those patients intolerant of pharmacologic therapies or those who have preference for nondrug treatments. This extensive review was done through analysis of all published articles in English on the topic of nutrition and nutraceutical supplements for the treatment of dyslipidemia that were available through the NIH and National Library of Congress publications (PubMed).
    Clinical Lipidology 06/2014; 9(3):333-354. DOI:10.2217/clp.14.25 · 0.87 Impact Factor
Show more